---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-116989"
form_type: "8-K"
ticker: "RXRX"
cik: "0001601830"
company_name: "RECURSION PHARMACEUTICALS, INC."
filed_at: "2025-05-09T23:59:59+00:00"
generated_at: "2026-05-22T01:42:17.656445+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Recursion registers 4.26M shares for resale by Tempus Labs under prior license agreement

## Summary
- Filed prospectus supplement to register 4,260,927 shares of Class A common stock for resale by Tempus Labs, Inc.
- Shares were issued as payment for annual license fees under a Master Agreement dated Nov 2023.
- Offering made under an exemption from registration; legal opinion filed as Exhibit 5.1.
- Registration does not involve new issuance of shares; existing shares held by Tempus.

## SEC filing metadata
- accession: 0001193125-25-116989
- form_type: 8-K
- ticker: RXRX
- cik: 0001601830
- company_name: RECURSION PHARMACEUTICALS, INC.
- filed_at: 2025-05-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1601830/000119312525116989/0001193125-25-116989-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1601830/000119312525116989/d947576d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-116989
- JSON: https://secwatch.observer/filing/0001193125-25-116989.json
- Plain text: https://secwatch.observer/filing/0001193125-25-116989.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.